A Caenorhabditis elegans model of insulin resistance: altered macronutrient storage and dauer formation in an OGT-1 knockout.

PubWeight™: 1.93‹?› | Rank: Top 3%

🔗 View Article (PMC 1183534)

Published in Proc Natl Acad Sci U S A on July 28, 2005

Authors

John A Hanover1, Michele E Forsythe, Patrick T Hennessey, Thomas M Brodigan, Dona C Love, Gilbert Ashwell, Michael Krause

Author Affiliations

1: Laboratories of Cell Biochemistry and Biology and Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA. jah@helix.nih.gov

Articles citing this

Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu Rev Biochem (2011) 4.95

Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol (2012) 2.74

The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim Biophys Acta (2009) 2.66

O-linked beta-N-acetylglucosamine (O-GlcNAc): Extensive crosstalk with phosphorylation to regulate signaling and transcription in response to nutrients and stress. Biochim Biophys Acta (2009) 2.64

Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am J Physiol Endocrinol Metab (2008) 2.40

O-GlcNAc regulates FoxO activation in response to glucose. J Biol Chem (2008) 2.27

The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci (2010) 2.22

Dynamic O-GlcNAc cycling at promoters of Caenorhabditis elegans genes regulating longevity, stress, and immunity. Proc Natl Acad Sci U S A (2010) 1.86

A PGC-1alpha-O-GlcNAc transferase complex regulates FoxO transcription factor activity in response to glucose. J Biol Chem (2008) 1.76

Structural insights into mechanism and specificity of O-GlcNAc transferase. EMBO J (2008) 1.63

Functional analysis of SPINDLY in gibberellin signaling in Arabidopsis. Plant Physiol (2006) 1.59

Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc Natl Acad Sci U S A (2006) 1.51

O-GlcNAc cycling: emerging roles in development and epigenetics. Semin Cell Dev Biol (2010) 1.50

In vivo imaging of Caenorhabditis elegans glycans. ACS Chem Biol (2009) 1.48

Regulation of the O-linked beta-N-acetylglucosamine transferase by insulin signaling. J Biol Chem (2008) 1.45

Metabolic response to iron deficiency in Saccharomyces cerevisiae. J Biol Chem (2010) 1.43

O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development. BMC Dev Biol (2009) 1.31

A Drosophila model of high sugar diet-induced cardiomyopathy. PLoS Genet (2013) 1.28

Requirement for O-linked N-acetylglucosaminyltransferase in lymphocytes activation. EMBO J (2007) 1.22

O-GlcNAc cycling: implications for neurodegenerative disorders. Int J Biochem Cell Biol (2009) 1.22

Chemical reporters for fluorescent detection and identification of O-GlcNAc-modified proteins reveal glycosylation of the ubiquitin ligase NEDD4-1. Proc Natl Acad Sci U S A (2011) 1.21

Cracking the O-GlcNAc code in metabolism. Trends Endocrinol Metab (2013) 1.21

Modification of histones by sugar β-N-acetylglucosamine (GlcNAc) occurs on multiple residues, including histone H3 serine 10, and is cell cycle-regulated. J Biol Chem (2011) 1.20

Evidence of the involvement of O-GlcNAc-modified human RNA polymerase II CTD in transcription in vitro and in vivo. J Biol Chem (2012) 1.18

The conserved NAD(H)-dependent corepressor CTBP-1 regulates Caenorhabditis elegans life span. Proc Natl Acad Sci U S A (2009) 1.14

Intracellular protein glycosylation modulates insulin mediated lifespan in C.elegans. Aging (Albany NY) (2010) 1.14

Protein O-GlcNAcylation in diabetes and diabetic complications. Expert Rev Proteomics (2013) 1.12

Control of protein and sterol trafficking by antagonistic activities of a type IV P-type ATPase and oxysterol binding protein homologue. Mol Biol Cell (2009) 1.06

Regulation of Dauer formation by O-GlcNAcylation in Caenorhabditis elegans. J Biol Chem (2009) 1.01

O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases. Proc Natl Acad Sci U S A (2012) 1.00

Molecular characterization of nucleocytosolic O-GlcNAc transferases of Giardia lamblia and Cryptosporidium parvum. Glycobiology (2008) 1.00

Metabolic labeling enables selective photocrosslinking of O-GlcNAc-modified proteins to their binding partners. Proc Natl Acad Sci U S A (2012) 0.98

Multiple tissue-specific roles for the O-GlcNAc post-translational modification in the induction of and complications arising from type II diabetes. J Biol Chem (2014) 0.98

Dynamic O-GlcNAcylation and its roles in the cellular stress response and homeostasis. Cell Stress Chaperones (2013) 0.98

Blocking O-linked GlcNAc cycling in Drosophila insulin-producing cells perturbs glucose-insulin homeostasis. J Biol Chem (2010) 0.98

Conditional knock-out reveals a requirement for O-linked N-Acetylglucosaminase (O-GlcNAcase) in metabolic homeostasis. J Biol Chem (2015) 0.97

A biochemist's guide to Caenorhabditis elegans. Anal Biochem (2006) 0.97

The roles of O-linked β-N-acetylglucosamine in cardiovascular physiology and disease. Am J Physiol Heart Circ Physiol (2012) 0.97

A lipid-droplet-targeted O-GlcNAcase isoform is a key regulator of the proteasome. J Cell Sci (2011) 0.96

O-linked-N-acetylglucosamine cycling and insulin signaling are required for the glucose stress response in Caenorhabditis elegans. Genetics (2011) 0.95

Mechanism, Structure, and Inhibition of O-GlcNAc Processing Enzymes. Curr Signal Transduct Ther (2010) 0.94

Elevated O-GlcNAc-dependent signaling through inducible mOGT expression selectively triggers apoptosis. Amino Acids (2010) 0.93

O-GlcNAcylation at promoters, nutrient sensors, and transcriptional regulation. Biochim Biophys Acta (2013) 0.91

Glycosylation of the nuclear pore. Traffic (2014) 0.90

Lifestyle-induced metabolic inflexibility and accelerated ageing syndrome: insulin resistance, friend or foe? Nutr Metab (Lond) (2009) 0.87

Survey of O-GlcNAc level variations in Xenopus laevis from oogenesis to early development. Glycoconj J (2008) 0.87

O-GlcNAc reports ambient temperature and confers heat resistance on ectotherm development. Proc Natl Acad Sci U S A (2014) 0.86

A critical perspective of the diverse roles of O-GlcNAc transferase in chromatin. Chromosoma (2015) 0.85

Environmental and genetic preconditioning for long-term anoxia responses requires AMPK in Caenorhabditis elegans. PLoS One (2011) 0.85

Protein O-GlcNAcylation: A critical regulator of the cellular response to stress. Curr Signal Transduct Ther (2010) 0.85

LC-MS proteomics analysis of the insulin/IGF-1-deficient Caenorhabditis elegans daf-2(e1370) mutant reveals extensive restructuring of intermediary metabolism. J Proteome Res (2014) 0.85

Quantitative phosphoproteomics reveals crosstalk between phosphorylation and O-GlcNAc in the DNA damage response pathway. Proteomics (2015) 0.85

Identification of O-linked N-acetylglucosamine (O-GlcNAc)-modified osteoblast proteins by electron transfer dissociation tandem mass spectrometry reveals proteins critical for bone formation. Mol Cell Proteomics (2013) 0.85

Sex differences in carbohydrate metabolism are linked to gene expression in Caenorhabditis elegans. PLoS One (2012) 0.84

Metabolic labeling of Caenorhabditis elegans primary embryonic cells with azido-sugars as a tool for glycoprotein discovery. PLoS One (2012) 0.84

Disruption of O-GlcNAc Cycling in C. elegans Perturbs Nucleotide Sugar Pools and Complex Glycans. Front Endocrinol (Lausanne) (2014) 0.83

MORPHIN: a web tool for human disease research by projecting model organism biology onto a human integrated gene network. Nucleic Acids Res (2014) 0.81

Shifts in the distribution of mass densities is a signature of caloric restriction in Caenorhabditis elegans. PLoS One (2013) 0.81

O-GlcNAc cycling shows neuroprotective potential in C. elegans models of neurodegenerative disease. Worm (2013) 0.80

Dual functionality of O-GlcNAc transferase is required for Drosophila development. Open Biol (2015) 0.80

O-GlcNAc modification of the coat protein of the potyvirus Plum pox virus enhances viral infection. Virology (2013) 0.79

O-GlcNAc cycling modulates neurodegeneration. Proc Natl Acad Sci U S A (2012) 0.79

Post-translational O-GlcNAcylation is essential for nuclear pore integrity and maintenance of the pore selectivity filter. J Mol Cell Biol (2015) 0.79

O-GlcNAc and aging: C. elegans as a genetic model to test O-GlcNAc roles in type II diabetic insulin resistance. Aging (Albany NY) (2010) 0.79

Glycogen Fuels Survival During Hyposmotic-Anoxic Stress in Caenorhabditis elegans. Genetics (2015) 0.79

The Early Metazoan Trichoplax adhaerens Possesses a Functional O-GlcNAc System. J Biol Chem (2015) 0.78

Protein O-GlcNAcylation: emerging mechanisms and functions. Nat Rev Mol Cell Biol (2017) 0.78

Post-translational modifications: A shift for the O-GlcNAc paradigm. Nat Chem Biol (2010) 0.77

Loss of C. elegans GON-1, an ADAMTS9 Homolog, Decreases Secretion Resulting in Altered Lifespan and Dauer Formation. PLoS One (2015) 0.76

Proteolysis of HCF-1 by Ser/Thr glycosylation-incompetent O-GlcNAc transferase:UDP-GlcNAc complexes. Genes Dev (2016) 0.75

O-GlcNAcylation of SKN-1 modulates the lifespan and oxidative stress resistance in Caenorhabditis elegans. Sci Rep (2017) 0.75

Synthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the Nematode Caenorhabditis elegans. G3 (Bethesda) (2016) 0.75

Evidence of a MOF histone acetyltransferase-containing NSL complex in C. elegans. Worm (2014) 0.75

Mutations in N-acetylglucosamine (O-GlcNAc) transferase in patients with X-linked intellectual disability. J Biol Chem (2017) 0.75

Articles cited by this

A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem (1957) 173.99

The genetics of Caenorhabditis elegans. Genetics (1974) 102.14

Systematic functional analysis of the Caenorhabditis elegans genome using RNAi. Nature (2003) 26.58

A C. elegans mutant that lives twice as long as wild type. Nature (1993) 20.42

Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature (2003) 14.49

MicroRNA pathways in flies and worms: growth, death, fat, stress, and timing. Cell (2003) 14.07

daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science (1997) 13.61

The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature (1997) 13.09

Functional genomic analysis of cell division in C. elegans using RNAi of genes on chromosome III. Nature (2000) 9.82

Genome-wide RNAi analysis of Caenorhabditis elegans fat regulatory genes. Nature (2003) 7.80

A systematic RNAi screen identifies a critical role for mitochondria in C. elegans longevity. Nat Genet (2002) 6.26

mRNA surveillance by the Caenorhabditis elegans smg genes. Genes Dev (1993) 5.94

Monoclonal antibodies identify a group of nuclear pore complex glycoproteins. J Cell Biol (1987) 5.79

The unc-86 gene product couples cell lineage and cell identity in C. elegans. Cell (1990) 4.87

The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc Natl Acad Sci U S A (2000) 4.55

daf-2, daf-16 and daf-23: genetically interacting genes controlling Dauer formation in Caenorhabditis elegans. Genetics (1994) 4.32

Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J Biol Chem (1997) 4.24

Glycosylation of nucleocytoplasmic proteins: signal transduction and O-GlcNAc. Science (2001) 4.13

Food and metabolic signalling defects in a Caenorhabditis elegans serotonin-synthesis mutant. Nature (2000) 4.01

SKN-1 links C. elegans mesendodermal specification to a conserved oxidative stress response. Genes Dev (2003) 3.92

Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J Biol Chem (2001) 3.39

The age-1 and daf-2 genes function in a common pathway to control the lifespan of Caenorhabditis elegans. Genetics (1995) 3.33

O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats. J Biol Chem (1997) 3.16

Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes. Proc Natl Acad Sci U S A (2002) 3.08

skn-1, a maternally expressed gene required to specify the fate of ventral blastomeres in the early C. elegans embryo. Cell (1992) 2.94

Mitochondrial endonuclease G is important for apoptosis in C. elegans. Nature (2001) 2.76

CeMyoD accumulation defines the body wall muscle cell fate during C. elegans embryogenesis. Cell (1990) 2.61

Characterization of a mouse monoclonal antibody specific for O-linked N-acetylglucosamine. Anal Biochem (2001) 2.58

Mitochondria and apoptosis. Eur J Biochem (1998) 2.58

Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability. Mol Cell Biol (2004) 2.56

An insulin-like signaling pathway affects both longevity and reproduction in Caenorhabditis elegans. Genetics (1998) 2.46

How death shapes life during development. Nat Rev Mol Cell Biol (2002) 2.43

The superhelical TPR-repeat domain of O-linked GlcNAc transferase exhibits structural similarities to importin alpha. Nat Struct Mol Biol (2004) 2.36

Mechanisms of AIF-mediated apoptotic DNA degradation in Caenorhabditis elegans. Science (2002) 2.36

Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci U S A (2002) 2.32

Genetics of programmed cell death in C. elegans: past, present and future. Trends Genet (1998) 2.19

Gibberellin signal transduction presents ellipsisthe SPY who O-GlcNAc'd me. Trends Plant Sci (1999) 2.07

Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J Biol Chem (2000) 2.05

The mitochondrial apoptosome: a killer unleashed by the cytochrome seas. Trends Biochem Sci (2001) 2.01

Programmed cell death: alive and well in the new millennium. Trends Cell Biol (2001) 1.96

Glycan-dependent signaling: O-linked N-acetylglucosamine. FASEB J (2001) 1.94

Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy. Proc Natl Acad Sci U S A (2003) 1.90

Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase. J Biol Chem (2002) 1.88

Two O-linked N-acetylglucosamine transferase genes of Arabidopsis thaliana L. Heynh. have overlapping functions necessary for gamete and seed development. Genetics (2002) 1.72

Mitochondrial and nucleocytoplasmic targeting of O-linked GlcNAc transferase. J Cell Sci (2003) 1.62

Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. Arch Biochem Biophys (2003) 1.49

A conserved transcription motif suggesting functional parallels between Caenorhabditis elegans SKN-1 and Cap'n'Collar-related basic leucine zipper proteins. J Biol Chem (2000) 1.45

Apoptosis without caspases: an inefficient molecular guillotine? Cell Death Differ (1999) 1.44

Insulin resistance of glycogen synthase mediated by o-linked N-acetylglucosamine. J Biol Chem (2003) 1.42

Apoptosomes: engines for caspase activation. Curr Opin Cell Biol (2002) 1.41

A metabolic model for life span determination in Caenorhabditis elegans. Dev Cell (2003) 1.40

Homology between O-linked GlcNAc transferases and proteins of the glycogen phosphorylase superfamily. J Mol Biol (2001) 1.35

SAGE surveys C. elegans carbohydrate metabolism: evidence for an anaerobic shift in the long-lived dauer larva. Mech Ageing Dev (2003) 1.26

Altered expression of SPINDLY affects gibberellin response and plant development. Plant Physiol (2001) 1.26

Suppression of CED-3-independent apoptosis by mitochondrial betaNAC in Caenorhabditis elegans. Nature (2003) 1.26

Apoptosis: corralling the corpses. Cell (2001) 1.19

MyoD and myogenesis in C. elegans. Bioessays (1995) 1.18

Mitochondria: execution central. FEBS Lett (2000) 1.15

Hyperglycemia and inhibition of glycogen synthase in streptozotocin-treated mice: role of O-linked N-acetylglucosamine. J Biol Chem (2004) 1.09

SKN-1 domain folding and basic region monomer stabilization upon DNA binding. Genes Dev (1997) 0.98

Hormesis in Caenorhabditis elegans dauer-defective mutants. Biogerontology (2003) 0.93

Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. Leukemia (2002) 0.86

Will fatty worms help cure human obesity? Trends Genet (2003) 0.85

The staining of glycogen with Best's Carmine and similar hydrogen bonding dyes. A mechanistic study. Histochem J (1971) 0.79

Articles by these authors

MYCN regulates oncogenic MicroRNAs in neuroblastoma. Int J Cancer (2008) 2.76

Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat Rev Mol Cell Biol (2012) 2.74

The hexosamine signaling pathway: O-GlcNAc cycling in feast or famine. Biochim Biophys Acta (2009) 2.66

Defining the transcriptional redundancy of early bodywall muscle development in C. elegans: evidence for a unified theory of animal muscle development. Genes Dev (2006) 2.33

Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci U S A (2002) 2.32

RNA editing by ADARs is important for normal behavior in Caenorhabditis elegans. EMBO J (2002) 2.14

Haem homeostasis is regulated by the conserved and concerted functions of HRG-1 proteins. Nature (2008) 1.95

GLI1 inhibition promotes epithelial-to-mesenchymal transition in pancreatic cancer cells. Cancer Res (2011) 1.81

The myogenic potency of HLH-1 reveals wide-spread developmental plasticity in early C. elegans embryos. Development (2005) 1.66

Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc Natl Acad Sci U S A (2006) 1.51

Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. Arch Biochem Biophys (2003) 1.49

Self-motion and the hippocampal spatial metric. J Neurosci (2005) 1.47

Loss of a FYN-regulated differentiation and growth arrest pathway in advanced stage neuroblastoma. Cancer Cell (2002) 1.44

Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates. Glycobiology (2006) 1.44

The embryonic muscle transcriptome of Caenorhabditis elegans. Genome Biol (2007) 1.35

Mixed-polarization phenotype of ascites-associated macrophages in human ovarian carcinoma: correlation of CD163 expression, cytokine levels and early relapse. Int J Cancer (2013) 1.27

O-GlcNAc cycling: implications for neurodegenerative disorders. Int J Biochem Cell Biol (2009) 1.22

The protein arginine methyltransferases CARM1 and PRMT1 cooperate in gene regulation. Nucleic Acids Res (2008) 1.16

Insulinoma-Associated Protein IA-2, a Vesicle Transmembrane Protein, Genetically Interacts with UNC-31/CAPS and Affects Neurosecretion in Caenorhabditis elegans. J Neurosci (2004) 1.11

Comprehensive phenotypic characterization of human adipose-derived stromal/stem cells and their subsets by a high throughput technology. Stem Cells Dev (2012) 1.10

Enzymatic characterization of O-GlcNAcase isoforms using a fluorogenic GlcNAc substrate. Carbohydr Res (2006) 1.10

Cyclin E expression during development in Caenorhabditis elegans. Dev Biol (2003) 1.04

Distinctive inhibition of O-GlcNAcase isoforms by an alpha-GlcNAc thiolsulfonate. J Am Chem Soc (2007) 1.04

Advances and Perspectives in the Molecular Diagnosis of Head and Neck Cancer. Expert Opin Med Diagn (2010) 1.03

Inhibitory effect of c-Myc on p53-induced apoptosis in leukemia cells. Microarray analysis reveals defective induction of p53 target genes and upregulation of chaperone genes. Oncogene (2005) 1.02

Transcriptional regulation. WormBook (2005) 1.02

O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases. Proc Natl Acad Sci U S A (2012) 1.00

Genome-wide analysis reveals novel genes essential for heme homeostasis in Caenorhabditis elegans. PLoS Genet (2010) 0.99

Blocking O-linked GlcNAc cycling in Drosophila insulin-producing cells perturbs glucose-insulin homeostasis. J Biol Chem (2010) 0.98

Characterization of a dominant negative C. elegans Twist mutant protein with implications for human Saethre-Chotzen syndrome. Development (2002) 0.96

A lipid-droplet-targeted O-GlcNAcase isoform is a key regulator of the proteasome. J Cell Sci (2011) 0.96

The High Mobility Group Box Transcription Factor Nhp6Ap enters the nucleus by a calmodulin-dependent, Ran-independent pathway. J Biol Chem (2007) 0.95

O-linked-N-acetylglucosamine cycling and insulin signaling are required for the glucose stress response in Caenorhabditis elegans. Genetics (2011) 0.95

Caudal-like PAL-1 directly activates the bodywall muscle module regulator hlh-1 in C. elegans to initiate the embryonic muscle gene regulatory network. Development (2009) 0.95

Neuron-transistor coupling: interpretation of individual extracellular recorded signals. Eur Biophys J (2005) 0.93

Elevated O-GlcNAc-dependent signaling through inducible mOGT expression selectively triggers apoptosis. Amino Acids (2010) 0.93

Comment on "Nonreciprocal light propagation in a silicon photonic circuit". Science (2012) 0.92

Heme utilization in the Caenorhabditis elegans hypodermal cells is facilitated by heme-responsive gene-2. J Biol Chem (2012) 0.89

Calmodulin-driven nuclear entry: trigger for sex determination and terminal differentiation. J Biol Chem (2009) 0.89

Evaluation of MYB promoter methylation in salivary adenoid cystic carcinoma. Oral Oncol (2011) 0.89

A widespread distribution of genomic CeMyoD binding sites revealed and cross validated by ChIP-Chip and ChIP-Seq techniques. PLoS One (2010) 0.87

In vitro and in vivo activity of frenolicin B against Plasmodium falciparum and P berghei. J Antibiot (Tokyo) (2011) 0.86

Mouse mammary tumor virus Env-derived peptide associates with nucleolar targets in lymphoma, mammary carcinoma, and human breast cancer. Cancer Res (2005) 0.86

Optimizing the selectivity of DIFO-based reagents for intracellular bioorthogonal applications. Carbohydr Res (2013) 0.86

Gene expression analysis after receptor tyrosine kinase activation reveals new potential melanoma proteins. BMC Cancer (2010) 0.86

Discovery of N-[(3R,5R)-1-azabicyclo[3.2.1]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide as an agonist of the alpha7 nicotinic acetylcholine receptor: in vitro and in vivo activity. Bioorg Med Chem Lett (2008) 0.86

Genome-wide localization and expression profiling establish Sp2 as a sequence-specific transcription factor regulating vitally important genes. Nucleic Acids Res (2012) 0.85

Solubilization of sagopilone, a poorly water-soluble anticancer drug, using polymeric micelles for parenteral delivery. Int J Pharm (2010) 0.84

Loss of the transcriptional repressor PAG-3/Gfi-1 results in enhanced neurosecretion that is dependent on the dense-core vesicle membrane protein IDA-1/IA-2. PLoS Genet (2009) 0.83

Transgenic C. elegans dauer larvae expressing hookworm phospho null DAF-16/FoxO exit dauer. PLoS One (2011) 0.82

OGA inhibition by GlcNAc-selenazoline. Bioorg Med Chem (2010) 0.82

Synaptic commitment: developmentally regulated reciprocal changes in hippocampal granule cell NMDA and AMPA receptors over the lifespan. J Neurophysiol (2008) 0.81

Polymeric micelles for parenteral delivery of sagopilone: physicochemical characterization, novel formulation approaches and their toxicity assessment in vitro as well as in vivo. Eur J Pharm Biopharm (2010) 0.80

Validation of a same-day real-time PCR method for screening of meat and carcass swabs for Salmonella. BMC Microbiol (2009) 0.80

Expression profiling reveals specific gene expression signatures in gastric MALT lymphomas. Leuk Lymphoma (2008) 0.80

Myogenic conversion and transcriptional profiling of embryonic blastomeres in Caenorhabditis elegans. Methods (2011) 0.79

Transcriptional regulation of gene expression in C. elegans. WormBook (2013) 0.79

Tunable Bragg reflectors on silicon-on-insulator rib waveguides. Opt Express (2009) 0.79

Crp79p, like Mex67p, is an auxiliary mRNA export factor in Schizosaccharomyces pombe. Mol Biol Cell (2002) 0.79

The signal peptide of mouse mammary tumor virus-env: a phosphoprotein tumor modulator. Mol Cancer Res (2012) 0.78

Analysis of Raman lasing characteristics in silicon-on-insulator waveguides. Opt Express (2004) 0.78

Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors. Bioconjug Chem (2014) 0.78

LIN9, a subunit of the DREAM complex, regulates mitotic gene expression and proliferation of embryonic stem cells. PLoS One (2013) 0.77

Chemical tools to explore nutrient-driven O-GlcNAc cycling. Crit Rev Biochem Mol Biol (2014) 0.77

"The dust hasn't settled yet": the National Q fever Management Program, missed opportunities for vaccination and community exposures. Aust N Z J Public Health (2007) 0.77

p53 and p73 in suppression of Myc-driven lymphomagenesis. Int J Cancer (2009) 0.77

Pituitary adenylate cyclase-activating polypeptide (PACAP) inhibits the slow afterhyperpolarizing current sIAHP in CA1 pyramidal neurons by activating multiple signaling pathways. Hippocampus (2013) 0.76

Measurement of nonreciprocal spontaneous Raman scattering in silicon photonic wires. Opt Express (2010) 0.75

Resonance splitting in gyrotropic ring resonators. Opt Lett (2010) 0.75

Backscattering and disorder limits in slow light photonic crystal waveguides. Opt Express (2009) 0.75

Variation of Zr-L2,3 XANES in tetravalent zirconium oxides. J Phys Condens Matter (2013) 0.75

Chapter 9: Benign sinonasal neoplasms. Am J Rhinol Allergy (2013) 0.75

4-(omega-(alkyloxy)alkyl)-1H-imidazole derivatives as histamine H(3) receptor antagonists/agonists. J Med Chem (2004) 0.75

Non-ionic dendritic glycerol-based amphiphiles: novel excipients for the solubilization of poorly water-soluble anticancer drug Sagopilone. Eur J Pharm Sci (2010) 0.75